The impact of continuous glucose monitoring on hospital point-of-care testing programs

Diabetes Technology and Therapeutics

Volumn 3, Issue 4, 2001, Pages 647-650

  Kiechle, Frederick L ^a  

^a WILLIAM BEAUMONT HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE OXIDASE; INSULIN;

BLOOD GLUCOSE MONITORING; CALIBRATION; COST EFFECTIVENESS ANALYSIS; DIABETES CONTROL; DIABETES MELLITUS; DIAGNOSTIC TEST; HEALTH CARE COST; HEALTH CARE FINANCING; HEALTH PROGRAM; HOSPITAL CARE; HUMAN; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; NON INSULIN DEPENDENT DIABETES MELLITUS; NOTE; PRIORITY JOURNAL; SELF CARE; SENSOR;

ADULT; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; COSTS AND COST ANALYSIS; DIABETES MELLITUS; HUMANS; MONITORING, AMBULATORY; POINT-OF-CARE SYSTEMS; UNITED STATES;

EID: 0035723598     PISSN: 15209156     EISSN: None     Source Type: Journal    
DOI: 10.1089/15209150152811298     Document Type: Note

References (40)

1. Report of the expert committee on the diagnosis and classification of diabetes mellitus
2. Insulin action: Implications for the clinical laboratory
3. Impaired glucose tolerance in the US population
4. Medical care expenditures for diabetes, its chronic complications, and its comorbidities
5. Utilization and cost analysis of bedside capillary glucose testing in a large teaching hospital: Implications for managing point of care testing
6. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus
7. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
8. Effect of intensive blood glucose control policy with metformin on complications in type 2 diabetes patients (UKPDS 34)
9. Who performs point-of-care testing?
10. Point-of-care testing: Administration within a health system
11. Glycemic control and sliding scale insulin use in medical inpatients with diabetes mellitus
12. Blood glucose: Measurement in the point-of-care setting
13. Bedside glucose testing. Applications in the home and hospital
14. Hazard report: Errors in using blood glucose monitors in hospitals
15. Office logistics: Implementation of the continuous glucose monitoring system in clinical practice
16. Fingerstick glucose determination in shock
17. Glucose monitoring: State of the art and future possibilities
18. Wearable microdialysis system for continuous in vivo monitoring of glucose
19. Can interstitial glucose assessment replace blood glucose measurements?
20. The MiniMed continuous glucose monitoring system
21. Clinical utility of the continuous glucose monitoring system
22. Noninvasive glucose monitoring. Comprehensive clinical results
23. Detection of hypoglycemia with the GlucoWatch biographer
24. ® biographer: A frequent, automatic and noninvasive glucose monitor
25. A subcutaneous glucose sensor with improved longevity, dynamic range, and stability of calibration
26. Spectroscopic and clinical aspects of non-invasive glucose measurements
27. Evaluation of measurement sites for noninvasive blood glucose sensing with near infrared transmission spectroscopy
28. Advances in photoacoustic noninvasive glucose testing
29. Glycemic control, mealtime glucose excursions, and diabetic complications in type 2 diabetes mellitus
30. Newer portable glucose meters-analytical improvement compared with previous generation devices?
31. In vitro diagnostics in diabetes: Meeting the challenge
32. Clinical usefulness of the glucose concentration in the subcutaneous tissue-properties and pitfalls of electrochemical biosensors
33. Nocturnal temperature and subcutaneous blood flow in humans
34. Effect of acetaminophen on the accuracy of the glucose measurements obtained with the GlucoWatch biographer
35. Influence of inflammatory cells and serum on the performance of implantable glucose sensors
36. Hardware and software in diabetes mellitus: Performance characteristics of handheld glucose testing devices and the application of glucose testing to patients' daily diabetes management
37. Patient-derived quality specifications for instruments used in self-monitoring of blood glucose
38. How attractive does a new technology have to be to warrant adoption and utilization? Tentative guidelines for using clinical and economic evaluations